thallium chloride has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akinboboye, O; Bergmann, SR; Berman, D; Germano, G; Gopal, A; Idris, O; Nichols, K | 1 |
| Fukuoka, S; Hamada, S; Hayashida, K; Hirose, Y; Ishida, Y; Kawano, S; Kuribayashi, S; Maeno, M; Ohe, T; Shimomura, K; Takahashi, N; Takamiya, M; Yamada, N | 1 |
1 trial(s) available for thallium chloride and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Left ventricular mass measured by myocardial perfusion gated SPECT. Relation to three-dimensional echocardiography.
Topics: Adult; Aged; Echocardiography, Three-Dimensional; Exercise Test; Female; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi; Thallium; Ventricular Dysfunction, Left | 2003 |
1 other study(ies) available for thallium chloride and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
[Significance of 123I-metaiodobenzylguanidine SPECT for detecting left ventricular involvement in patients with arrhythmogenic right ventricular dysplasia].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Humans; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Tachycardia, Ventricular; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 1996 |